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Summary
Two prior studies with a small number ofT cell lines have shown that the presentation of native
protein antigens by epidermal Langerhans cells (LC) is regulated . When freshly isolated, LC
are efficient antigen-presenting cells (APC), but after a period of culture LC are inefficient or
even inactive. The deficit in culture seems to be a selective loss in antigen processing, since cultured
LC are otherwise rich in major histocompatibility complex (MHC) class II products and are
active APC for alloantigens and mitogens, which do not require processing . We have extended
the analysis by studying presentation to bulk populations of primed lymph node and aTT hybrid .
Only freshly isolated LC can be pulsed with the protein antigens myoglobin and conalbumin,
but once pulsed, antigen is retained in an immunogenic form for at least 2 d . The acquisition
of antigen, presumably as MHC-peptide complexes, is inhibited if the fresh LC are exposed to
foreign protein in the presence ofchloroquine or cycloheximide. The latter, in contrast, improves
the efficacy ofantigen pulsing in anti-Ig-stimulated B blasts. In additional studies of mechanism,
we noted that both fresh and culturedLC endocytose similar amounts of an antigen, rhodamine-
ovalbumin, into perinuclear granules . However, freshly isolatedLC synthesize high levels of class
II MHC molecules and express higher amounts of the class II-associated invariant chain . Fresh
LC are at least 5-10 times more active than many other cell types in the level of biosynthesis
ofMHC class II products. These findings provide a physiologic model in which newly synthesized
MHC class II molecules appear to be the principal vehicle for effective antigen processing by
APC of the dendritic cell lineage . AnotherAPC, the B lymphoblast, does not appear to require
newly synthesized MHC class II molecules for presentation .
T
he solution by Bjorkman et al. (1) of the crystal struc-
ture ofMHC class I molecules, and the evidence from
many laboratories that small peptides are stimulatory for T
cells (2-11), have provided direct evidence thatMHC-peptide
complexes are the ligand recognized by the TCR. Nonethe-
less it remains difficult to monitor the formation ofMHC-
peptide complexes on living APC, and to study the mecha-
nism of complex formation .
The principal approach for studying mechanisms of pre-
sentation is to use inhibitory compounds. For class IIMHC
products, agents like chloroquine that neutralize intracellular
acidic compartments (12) block presentation of many pro-
tein antigens (13) . A lowpH may be required for proteolysis
by acid hydrolases (13), association of peptides with class II
(14), or release of the invariant chain from its complex with
class II (15) . The inhibitor of protein synthesis, cyclohexi-
mide (CHX)t, also blocks class II presentation but only by
peritoneal cells (16) and not by a B cell line (17) . The site
of action ofCHX is unclear. It may be at the level ofMHC
class II biosynthesis, as suggested by analogy with the re-
quirements for presentation by class IMHC products. Brefeldin
A, which interferes with the egress ofproteins from the rough
'Abbreviations used in thispaper:cm, cyeloheximide ; EC, epidermal cells;
LC, Langerhans cells ; RER rough endoplasmic reticulum ; rho-ova,
rhodamine ovalbumin ; SpWMb, sperm whale myoglobin .
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Townsend et al. (20), by studying a variant cell line that fails
to express class I at the cell surface, found that exogenous
peptides can direct the assembly of newly synthesized 02
microglobulin-class I heterodimers before the brefeldin-
sensitive point in protein export . So for both class I and II,
newly synthesizedMHC products may be an important site
for charging these molecules with peptides.
An alternate approach to unraveling the requirements for
processing and presentation would be to identify physiologic
situations in which the efficacy of these events is regulated .
One such possibility has arisen in studies of antigen presen-
tation by dendritic cells. When freshly isolated from both
epidermis (21, 22) and spleen (23), dendritic cells can present
native proteins . However, after a day in culture, presentation
of proteins markedly decreases . This change is not due to
a loss of antigen-presentingMHC products, because the levels
of these products increase in the cultured Langerhans cells
(LC), and the LC present peptide fragments. Cultured LC
are fully capable of inducing T cell growth andDNA syn-
thesis as well, since they are the most active accessory cell
yet identified for stimulating responses to alloantigens and
mitogens . The latter do not require de novo antigen pro-
cessing . Therefore, it appears that cultured LC are selectively
deficient in the mechanism for processing antigens intoMHC-
peptide complexes, but in contrast express all the additional
machinery for stimulating T cells.
Here we analyze some of the potential sites at which pro-
cessing may differ between fresh and culturedAPC . One vari-
able, endocytic activity, does not seem to diminish in cul-
ture, but two other variables change markedly . The freshly
isolated LC actively synthesizeMHC class II products, and
these LC express high levels ofinvariant chain . Cultured LC
are negative in both regards . Based on these findings and the
sensitivity of presentation by fresh LC to CHX, we propose
that newly synthesized MHC products are quantitatively an
important venue for antigen processing and presentation in
dendritic cells . This is not the case for the APC function of
stimulated B lymphoblasts .
Materials and Methods
Animals.
￿
Female CD2F1 mice were purchased from The Tru-
deau Institute (Saranac Lake, NY) and used at 8-12 wk of age .
Reagents .
￿
Antigens used in this study were sperm whale myo-
globin (SpWMb) and conalbumin (Sigma ChemicalCo., St . Louis,
MO) . A myoglobin peptide, representing amino acids 106-118 with
an additional NH2-terminal tyrosine residue, was synthesized by
The Rockefeller University Sequencing Facility. Chloroquine and
CHX (Sigma Chemical Co .) were used at the doses indicated . All
cells were cultured in RPMI 1640 medium supplemented with an-
tibiotic, antimycotic, 2 mM glutamine, 50 p.M /3-ME, and 5-10%
heat inactivated fetal calf serum .
Antigenpresenting Cells .
￿
Epidermal cells (EC) were prepared
from ear epidermal sheets as described (24) . Briefly, freshLC were
enriched from bulk epidermal cells by treatment with anti-thy-1
and complement followed by trypsin . This depletes -90% of the
keratinocytes, so that the preparations contain 10-15% Ia+ LC .
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LC were enriched from culturedEC by flotation on BSA columns
(24) . These preparations contained 30-80% Ia' LC .
Anti-Ig blasts were prepared as described (25) . Briefly, spleen
cells were depleted ofred cells (ammonium chloride lysis), T cells
(mAb and complement), and adherent cells (passage over Sephadex
G-10). The purifiedB cells were cultured with Sepharose-coupled
goat anti-mouse Ig antibodies for 48 h . The blasts were harvested
by Ficoll-Nque (Pharmacia Fine Chemicals, Piscataway, NJ) den-
sity gradient centrifugation .
AllAPC were exposed to 900 rad from a cesium source immedi-
ately before coculture with T cells . The APC either were added
directly with antigen to T cells (continuous exposure), or theAPC
were "pulsed" with antigen for 12-16 h before washing and addi-
tion toT cells in the absence ofadditional antigen. The final volume
was 200 ul in flat-bottom microwells .
T Cells.
￿
TheT cell hybridoma 11.3.7eH2 was obtained by fu-
sion of the SpWMb-specific, I-Ed-restricted T cell clone 11.3.7 .e
(26) with the BW5147 TCR-cx - /(3- cell line (27) . 3 d before fu-
sion, the T cell clone was restimulated as previously described (26)
in the presence of 5 U/ml ofhuman rIIr2 (Cetus Corp, Emeryville,
CA) . After removal of dead cells on a Ficoll-Paque gradient 2-10
x 106 cells were fused with 40 x 106 BW5147 cells as described
(28) . The 11.3.7eH2 T cell hybridoma (referred to hereon as 11 .3 .7)
was assayed for antigen specificity by 11,2 production in response
to a series of SpWMb peptides and syngeneic APC. The antigen
fine specificity oftheT cell hybridoma was indistinguishable from
the 11.3.7e clone . Stimulation ofthe T-T hybridoma cells was moni-
tored by assaying the conditioned media, harvested at 24 h after
culturing with APC, on the IIr2-dependent CTLL line . CTLL
were plated at 5 x 10' per well and pulsed with 0.5 p,Ci of
['HJTdR during the last 4 h of a 24-h assay. Data shown were ob-
tained with a subsaturating dose of 25 E .cl of test supernatant .
Primary populations ofantigen-primed LN cells were obtained
from popliteal and brachial LN 10 d after priming the footpads
with 100 jug ofprotein inCFA . TheLN cells were not used directly,
because of the high "background" proliferation (syngeneic MLR)
that occurs when dendritic cells are mixed with primary T cells
in the absence ofantigen (29) . Instead, as described elsewhere (23),
the LN cells were expanded in vitro with protein antigen in the
presence of 0.5% heat-inactivated mouse serum . 10--12 d later, the
cultures were harvested and floated on Ficoll-Paque columns to iso-
late viable cells . The latter were used as responders at a dose of
3 x 10° per microtest well in the presence ofClick's medium with
antibiotics, 50 AM O-ME, and 0.5% mouse serum .
Pinocytosis of Rbodamine-conjugated Ovalbumin .
￿
Pinocytosis by
LC was monitored after exposure to 0 .1 mg/ml rhodamine-
ovalbumin (rho-ova), (Molecular Probes, Inc ., Eugene, OR) at
0-16 h or 50-66 h, which were the conditions used to pulse APC
in all of our presentation experiments. No uptake could be observed
with only a 2-h exposure to rho-ova . After washing, the epidermal
cells were spun onto slides, stained with M5/114 mAb to mouse
la antigens plus FITC mouse anti-rat Ig to identify the LC, and
examined by two-color fluorescence microscopy.
Radiolabeling ofLC and Immunoprecipitation.
￿
Cells were methi-
onine starved for 1 h in methionine-free media and then labeled
with 1 mCi [ssS]methionine (Trans "S-label ; ICN Radio-
chemicals, Irvine, CA) for 4 h at 37°C supplemented with 2%
dialyzedFCS. After washing in FCS-containing medium, the cells
were lysed in 1% NP-40. Alternatively, 2 x 106 LC were surface
radioiodinated with 3 mCi ofNa"I (1 Ci-37GB1 ; New England
Nuclear, Boston, MA) by the lactoperoxidase/glucose oxidase
method, washed extensively, and lysed in 1% NP-40 . The 10,000-g
postnuclear extracts obtained from either of these lysates wereprecleared twice with 50 jig/ml normal rat Ig and rabbit anti-rat
Ig, adsorbed to protein A-Sepharose, andtwice again with anti-rat
Ig adsorbed to protein A-Sepharose . The precipitates were washed
sequentially with Dulbecco's modified PBS (PD) three times, high
salt buffer (0.6M NaCl, 12.5 mM KP04, pH 7.4, 0.02% NaN3),
mixed detergent buffer (0.05% NP-40, 0.1% SDS, 0.3M NaCl,
10 mM Tris, pH 8.6) and PD before suspension and boiling in
SDS-PAGE running buffer containing 50mM dithiothreitol. Eluates
were resolved in 10% polyacrylamide slab gels using the buffer
system of Laemmli (30) . Gels were stained with Coomassie blue
to detect standard . Gels of 31S samples were enhanced before
drying andexposure to Fuji x-ray film at -70°C with Cronex-Hi-
Plus intensifying screens (Dupont Co., Wilmington, DE) .
The antibodies used for immunoprecipitations were anti-la
(I-AbA9, I-Ed.k ; 50% culture supernatant from hybridoma
M5/114.15.1; ATCC TIB 120; reference 31); anti-I-Ab.d (1321.2,
ATCC TIB 229; reference 32) ; anti-I-Ed.k (14-4-4S, ATCC HB
32); NLDC145 to interdigitating cells (33) ; and rabbit anti-mouse
invariant chain (Ii) 99-112 peptide antibody that was provided by
Dr.V Quaranta (Scripps Clinic, La Jolla, CA). Class II molecules
and invariant chains also were identified by immunoperoxidase
labeling of cytospun epidermal cell suspensions with M5/114
and In-1 (34) mAb, provided by Dr. N. Koch, (Institut fur Im-
munologie and Genetik Deutsches Krebsforschungszentrum,
Heidelberg, FRG) followed by POX-mouse anti-rat Ig (Boerhinger
Mannheim Diagnostics, Inc., Houston, TX).
Results
Antigen Presentation by Fresh andCulturedLC to PrimedLymph
Node T Cells. Prior studies with a small number ofT cell
lines (21, 22)hadindicated that freshly isolated, but not cul-
tured, EC couldpresent native proteins . We used bulk popu-
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O Ag pulse 0-1d
11 Ag pulse 0-1 d. culture 1-3d
0 Ag pulse 0-3d
e Culture 0-1d, pulse 1-3d
lations ofLN T cells to see ifthis marked decrease in protein
presentation wasgenerally applicable. First, protein antigens
were added directly to theEC-T cell cocultures, andDNA
synthesis was measured 3 d later as an index of the T cell
response . It was evident that freshly isolated epidermalpopu-
lations couldpresent either myoglobinor conalbumin to LN
T cells, but epidermal cells that had been cultured for 1-3
d were inactive (Fig. 1, top) . Cultured EC did present pep-
tide fragments, however, and thus were similar to spleen den-
dritic cells (Fig. 1, top) .
Comparable results were obtained when epidermal cells
were pulsed with antigen, washed, and then cocultured with
sensitized T cells . I£ the protein was administered from day
0-1 or day 0-3 of culture, the pulsed cells triggered aT cell
response (Fig. 1, bottom) . The effective dose of epidermal LC
was only 1% of the required dose of spleen cells, and the
maximal response was greater (not shown, but see below) .
If the protein was administered from day 0-1 of culture, and
then the cells were washed and cultured 2 d before testing
for APC function, the pulsed EC remained active (Fig. 1,
bottom). However, ifthe proteinwas administered for the last
2 d of a 3-d epidermal culture, the LC acquired little or no
presenting function (Fig. 1, bottom) . Therefore, only freshly
isolated LC seem to be able to acquire protein antigens in
an immunogenic form . Once antigen is captured, it is
efficiently retained, since the cells can be washed and cul-
tured for 2 d before use as APC.
One explanation for the different capacities of fresh and
cultured LC to present protein antigens was that the fresh
EC were selectively contaminated with cell types other then
LC, capableof processing themyoglobin and then providing
Figure 1.
￿
Freshlyisolatedbut notculturedLC present
myoglobin and conalbumin to antigen-primed lymph node
cells . (Top) Four populations ofAPC were irradiated and
added in graded doses of la' cells to a constant dose of
3 x 104LN T cells that had been primed to myoglobin
or conalbumin (see Materials and Methods) . The APC
were spleen dendritic cells (DC), fresh epidermal cells (EC,
10-15% la'), EC cultured for 1 d (30-40% Ia*), and
EC cultured for 3 d(40-60% la*) . Shown here areDNA
synthesis data when theAPC and T cells were cultured
in the continuous presence of 5 FM protein or 0 .5 pM
myoglobinpeptide (residues105-118) . Notshown are the
lack ofresponses (<1,500 cpm) when antigen was omitted,
or when the inappropriate protein was added (i .e., myo-
globin to conalbumin-primedT cells or viceversa). (Bottom)
Epidermal cells were cultured with myoglobin or conal-
bumin at 100Ag/ml as indicated in the key. The cells were
enrichedby flotation on denseBSA columns, and washed
several times before being added is graded doses of Ia*
cells to antigen-primed T cells. Not shown are the lack
ofresponseswhen myoglobin-pulsed APC were cultured
with conalbumin-primed T cells and vice versa.Table 1 .
￿
Fresh Keratinocytes Do Not Provide Significant Amounts of Peptides for Presentation by Langerhans Cells
peptides for presentation by the LC . This was addressed by
mixing Ia- fresh epidermal cells with cultured EC and
testing ifthe former provided myoglobin peptides that could
be presented to lymph node T cells or T-T hybrids. Mix-
tures of Ia- epidermal cells and cultured EC did not present
myoglobin (Table 1) .
LN
￿
d0 EC
d0, Ia - EC
d3 EC
Mix of d0, Ia- EC + d3 EC
11.3 .7 hybridoma
￿
d0 EC
d0, Ia - EC
d3 EC
Mix of d0, la - EC + d3 EC
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[3H]TdR Incorporation
T cells
￿
APC
T cells were obtained from lymph nodes that hadbeen primed with either conalbumin or myoglobin in CFA (see Materials and Methods) . The
T cells were cultured with different populations ofAPC ± the specific protein at 100 Rg/ml . The EC populations, except when treated with a-la
and complement, contained 104 la+ LC . 3H-TdR was added to measureDNA synthesis at 60-72 h .
t 5 x 104 11.3.7 hybridomaT cells were cultured with 3 x 103 of different populations ofAPC ± native SpWMb or myoglobin peptide 106-118 .
24-h culture supernatant was assayed for CTLL growth activity .
Fresh and Cultured LC Accumulate Comparable Levels of a
Rhodamine ConjugateofOaalbumin . Another possible reason
for the lack ofpresentation by cultured EC was a loss in the
ability to take up exogenous antigen for intracellular pro-
cessing. The endocytic activity of LC is known to be weak
in situ (35), but we were able to detect uptake in vitro by
Figure 2.
￿
Pinocytosis by LC after exposure to 100 Ag/ml rho-ova at 0-16 h (A-C) or 50-66 h (D, E) of culture. After washing, the EC were
spun onto slides and stained with M5/114 mAb to mouse la antigens followed by FITC mouse anti-rat Ig. x300 . (A) Phase contrast with the three
LC arrowed. (B) Anti-la stain (FITC optics) to identify the LC . (C) rho-ova binding (RITC optics) showing binding to keratinocytes and uptake
into perinuclear granules in each LC (arrows) . Little or no labeling of LC was observed with a2-h exposure to tracer, but the keratinocytes did label
and even at 4°C . (D) Anti-la stain (FITC optics) ofa cultured epidermal preparation. (E) rho-ova uptake (RITC optics) by cultured LC into perinuclear
granules (arrows) . The extent of LC labeling with rho-ova is minute relative to what is observed with peritoneal macrophages, which are so active
in pinocytosis that the entire cell is brightly fluorescent (23) .
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using rho-ova as a tracer and fluorescence microscopy. Both
fresh (Fig. 2,A-C) and cultured (Fig . 2,D and E) LC identified
by two-color fluorescence with FITC anti-Ia and morphology,
appeared to internalize the protein into perinuclear granules
to a comparable extent. Ia - keratinocytes bound substantial
amounts of rho-ova (Fig. 2 C), but this was not immuno-
genic (Table 1) .
Presentation ofProtein by FreshEC to T-T Hybridoma Cells
Is Sensitive to Chloroquine and Cycloheximide. To evaluate the
effects of inhibitory compounds, we used as a homogeneous
Table 2.
￿
Effect of Chloroquine and CHX on the Presentation of Native Myoglobin and a Dominant Peptide Fragment
to the 11.3.7.1 Hybridoma
Exp.
Number in parentheses are percent of control .
Fresh or 2.5-d cultured, thy-1 - epidermal cells, or 2-d anti-Ig activated B blasts, were either untreated or pulsed with 100 t~g/ml SpWMb for 16 h
in the presence or absence of 2.5 F+g/ml CHX or 100 AM chloroquine . After 16 h the cells were harvested, washed, added in graded doses to 5 x
104 T-T hybridoma cells, and IL-2 release was measured at 24 h. In the indicated column, 2 AM myoglobin peptide 106-118 was added directly
to the cocultures of APC that had not been pulsed with antigen, and T hybridomas . Shown here are the IL-2 bioassay results with 103 LC in Exp .
1 and 3 x 103 LC or 5 x 104 B blasts in Exp 2 . In addition we monitored the effects of drug treatment on the expression of surface MHC class
11 molecules using the M5/114 mAb, FITC mouse anti-rat Ig, and a FACScan instrument. Chloroquine did not significantly reduce expression
of surface MHC class 11 products, but CHX had a significant effect . Specifically, themean fluorescence intensity in arbitrary units was 202 for fresh
LC; 1,069 for LC cultured 16 h without antigen or CHX; 1,018 for LC cultured 16 h with antigen only; 513 for LC cultured 16 h with CHX
only; and 404 for LC cultured with antigen andCHX.
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Figure 3 .
￿
Antigen presentation to the 11 .3 .7 T-T
hybridoma . Fresh (A) or 2-d cultured (B) LC were
cultured for 16 h in the presence (closed circle) or ab-
sence (open circles) of100 Fag/ml intactSpWMb. After
16 h the cells were harvested and washed, and the in-
dicated numbers of la+ cells were cocultured with 5
x 10 4 11.3.71T hybridoma cells . LC that had not
been pulsed with myoglobin were also tested for their
capacity to present the 106-119 peptide at 100 ug/ml
(triangle) . In C, LC (open symbols) are compared with
bulk spleencells (closedsymbols) for presentation ofpro-
tein administered as a 16 h pulse (triangles) or peptide
administeredcontinuously (squares) . Presentationwas
monitoredby assaying 25 Al of a 24 h culture super-
natant on theIIr2-dependent CTLL line. Other doses
of supernatant were tested for growth factor but are
not shown .
source of T cells the T-T hybrid 11.3.7eH2. After a 16-h
pulse with 100 p,g/ml of native myoglobin, day 1 EC (Fig.
3A) but not 3 d cultured EC (Fig. 3 B) were potent stimu-
lators of 11,2 release from 11.3.7eH2 . Similarly, fresh EC but
not cultured EC could present myoglobin protein when it
was added continuously to theAPCT hybrid cocultures (data
not shown) . However, the identical preparations of 1- and
3-d culturedEC could present the myoglobin peptide 106-118
to the T-T hybrid (Fig . 3, A and B) . The efficiency of EC
as APC was much greater than that of spleen cells (Fig . 3
APC Chloroquine
[3H
No Ag
TdR incorporation
Protein pulse Peptide Exp. APC CHX
[3H]TdR incorporation
No Ag Protein pulse Peptide
cpm x 10-3 cpm x 10-3
d1 LC - 2 .4 8.5 34.7 2 d1 LC - 5.9 42.6 48 .5
+ 1.8 1 .0 29.4 + 5.4 9.5 23.8
(12)- (85) (22) (49)
d3 LC - 2.2 0 29.1 d3 LC - 6.7 0 11.8
+ 2.8 0 31 .5 + 6.4 0 14.3
(108) (121)
B blasts - 0.6 2.7 7.0
+ 2.9 10.8 8 .9
(400) (127)Figure 4 .
￿
High level synthesis of MHC class II molecules by freshly isolated epidermal LC and its downregulation by day 1 and day 3 of in vitro
culture. (A) Lysate from -106 freshly isolated (lane 0) or 3-d cultured (lane 3) epidermal LC from CxDZF, H-2d mice were reacted with anti-Ia (left)
or NLDC145 anti-interdigitating cellmAb (right) . Immune complexes were precipitated with rabbit anti-rat Ig adsorbed to protein A-Sepharose. The
gel was exposed for 2 d . (B) I-A and I-E were analyzed separately by precipitation with anti-I-Ab .d (1321-2), anti-I-Ed.k (14-4-4S), or anti-I-A and I-E
(M5/114) as above. Epidermal cells were either labeled immediately after isolation (lanes 0) or after 1 or 3 d of culture (lanes 1 and 3, respectively) .
The final preclears for each lysate are shown in lanes marked pcl.
C) . The optimal number of epidermalLC was routinely 1-3
x 103 per 5 x 104 T hybridoma cells, while for spleen cells
it was 1-3 x 105 , and the maximal response was always
greater with EC . At supraoptimal numbers ofAPC, responses
decreased .
Chloroquine was tested as an inhibitor of presentation .
When fresh LC were pulsed with myoglobin in the presence
of chloroquine, presentation was markedly reduced (Table 2,
Exp . 1) . Peptide presentation by the chloroquine-treated cells
was not inhibited.
During the first 12-18 h in culture, the level ofMHC class
II molecules on the LC surface increased at least fivefold (36,
37) . This process is CHX sensitive (36) . We therefore tested
ifCHX could block presentation. At a dose of 2.5 Ftg/ml,
CHX reduced [ 3H]leucine incorporation into protein by
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85-95% during a 12-h labeling. Correspondingly, the increase
in surface Ia expression during this time was only 2-fold rather
than a 5-10 increase observed in control cells not treated with
CHX (see legend to Table 2) . The small increase in Ia ob-
served in the presence ofCHX might reflect class II mole-
cules that were synthesized beforeCHX could exert its effect,
e.g., in a preformed intracellular pool of Ia . Presentation of
myoglobin by antigen-pulsed, CHX-treated, day 1 LC was
markedly reduced (Table 2) . There was also a partial reduc-
tion in the ability of CHX-treated day 1 LC to present pep-
tide, possibly due to a reduction in surface class II, but there
was no reduction in peptide presentation by CHX-treated
day 3 LC (Table 2) .
When another APC, the activated anti-Ig blast, was tested,
CHX did not reduce presentation of myoglobin to the T-TFigure 5 .
￿
Freshly isolated and 3-d cultured LC both express high levels
ofsurface class II but surface invariant chain is only detected on fresh LC.
Lysates from 2 x 106 radioiodinated LC were precipitated with anti-la
mAb as in Fig . 3. Invariant chain (Ii) was precipitated with a rabbit anti-
mouse invariant chain 99-112 peptide antibody.
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hybrid, and typically enhanced it (Table 2) . The results with
the anti-Ig blasts are consistent with those reported for the
A20 B cell lymphoma where presentation was CHX resis-
tant (17) . The LC behave more like peritoneal cells studied
by Jensen (16) in being CHX sensitive.
High Rate Synthesis ofMHC Class II Molecules in Fresh LC
and Its Selective Downregulation During In Vitro Culture. To
test if class II molecules were potentially the site of theCHX
effect, we studied their biosynthesis in [35S]methionine-
labeled cultures . Fresh LC exhibited a remarkably high rate
of synthesis of Ia, allowing for detection in the relatively small
numbers of fresh LC that were available for such studies (Fig.
4 A) . The level of incorporation of label into la antigens in
fresh LC was greater than in 5-10-fold asmany cells ofother
cell types labeled in parallel, including 2-d anti-Ig blasts, fresh
peritoneal exudate cells, low density spleen cells, and 1 d cul-
tured spleen dendritic cells (data not shown) . In contrast,
la synthesis was not detectable in 3-d cultured LC (Fig. 4 A,
leftpanel, lane 0 vs. 3) . Additional studies compared LC la-
beled at 0-4, 20-24, and 68-72 h of culture. The synthesis
of both I-A and I-E MHC class II products was no longer
detectable by the first day of culture (Fig. 4 B) . This is con-
sistent with the loss ofAPC function ofLC by day 1 of cul-
ture (above) .
Two findings indicated that the marked decrease in Ia bio-
synthesis during culture was selective . Another surface an-
tigen that is recognized by themAb NLDC145 (33) was syn-
thesized more actively by day 3 than day 0 LC (Fig. 4 A,
Figure 6 .
￿
Expression ofclass II
MHC products and associated in-
variant chain in LC : immunoperox-
idase staining of acetone-fixed cy-
tospin preparations. LC in the fresh
epidermal cells (A and C) stain with
both anti-MHC class II (M5I114
mAb ; A) and anti-invariant chain
(In-1 ; C) mAb . LC in the cultured
epidermal cells (bottom) stain strongly
with anti-MHC class II (B), but not
detectablywith anti-invariant chain
(D) . x300.right), and there was comparable labeling of nonspecific bands
in the immunoprecipitates, particularly one at 45 kD (Fig .
4 A) .
To verify that the preparations of day 3 cultured EC ex-
pressed typical class II MHC products on the cell surface,
we did surface radiniodination studies . The levels of radioio-
dinated surface la precipitated from culturedLC was at least
comparable to the level of la precipitated from cultured LC
(Fig . 5), in spite of the loss of la biosynthesis by day 1 of
culture. This indicates that at least a significant proportion
ofthe Ia synthesizedby freshly isolatedLC is stably expressed
for at least 2-3 d .
MHC Class II-associated Invariant Chain (Ii) Expression in
LC. The invariant chain has been implicated in antigen pre-
sentation by fibroblast cell lines that have been transfected
with both invariant andMHC class II genes (38) . Immuno-
precipitation of Ia with a rabbit anti-mouse invariant chain
peptide antibody strongly suggests that invariant chain was
present on the surface of freshly isolated, but not cultured,
LC (Fig . 5, left lanes) .
We also examined the expression of invariant chain using
the mAb In-1, which reacts with the cytoplasmic domain
of the protein (34) . Cytospin preparations showed strong
staining by In-1 in the cytoplasm of most of the fresh LC
(Fig. 6 C) . Only a small proportion ofculturedLC were stained
by the In-1 and even in the positive cells the staining was
less intense than in the fresh LC (Fig. 6 D) . The cultured
LC were stained intensely withmAb to the class II heterodi-
mers (Fig. 6,A and B) . Under the same experimental condi-
tions, we detected low levels of la associated invariant chain
in B cells and greater levels in anti-Ig activated B lympho-
blasts (our unpublished observations) .
Discussion
The Distinct Antigenpresenting Features ofEpidermalLC.
￿
LC
are the dendritic APC of the epidermis (24, 39-41) . When
freshly isolated, LC can present exogenous protein antigens
to T cell clones (21, 22) and are 100 times more effective than
a standard population ofAPC, spleen cells (21) (Fig. 3) . Within
1 d in culture, LC lose the ability to present native protein .
We find that this downregulation occurs for two proteins
and for primary populations of responding T cells (Fig. 1) .
In addition, after an exposure to protein, the LC can retain
the antigen in immunogenic form for at least an additional
2 d in culture (Fig. 1, bottom) . This differs dramatically from
the reported loss ofimmunogen from antigen-pulsedB cells
within 8-12 h (42) . To our knowledge no other APC, ex-
cept spleen dendritic cells (23), display comparable traits of
potency, downregulation of protein presentation, and pro-
longed antigen retention .
Perhaps the downregulation of antigen processing and the
prolonged retention of antigens are related. If LC were to
generate antigenic peptides continuously for days, without
anynew synthesis ofMHC products (Fig. 4, and see below),
previously acquired peptides might be displaced . The physi-
ologic role ofLC may be to carry antigens via the lymph
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to T cells in the draining lymphoid tissue (40, 43) . These
events may require a period of days in which antigens that
are picked up in the skin have to be retained for presentation
to T cells that recirculate through lymph nodes.
While cultured LC do not present native proteins, they
are not deficient in many of the other properties required
of APC . In fact, cultured LC express the highest levels of
antigen-presentingMHC products among leukocytes (24, 36,
37), retain the ability to present peptide antigens to T cells
(21) (Figs. 1 and 3), and are the most potentAPC for foreign
MHC molecules and mitogens (24, 44) that do not require
de novo processing. Further studies are needed to evaluate
the efficacy of peptide presentation by fresh and cultured LC,
since we have only tested a single relatively high dose of 0.5
p,M (Figs . 1 and 3) . Nevertheless cultured LC represent a
physiologicAPC in which there appears to be a selective loss
of the capacity to process exogenous proteins, thereby pro-
viding an important model for studies of mechanism .
The Endocytic Activity ofLC.
￿
The presentation ofproteins
requires a chloroquine-sensitive step within acidic intracel-
lular vacuoles to which antigens can gain access by endocy-
tosis (13) . Alternatively, proteins can be processed extracel-
lularly (45) . Antigen processing by fresh LC likely occurs
intracellularly, since it is sensitive to chloroquine (Table 2) .
Dendritic cells exhibitweak endocytic activity (46), at least
relative to the level ofendocytosis exhibited by macrophages .
However, most of the endocytic activity in macrophages is
directed to antigen scavenging and destruction rather than
presentation (47) . The uptake ofantigens into dendritic cells
may be directed more to presentation . In a sense, dendritic
cells resemble B lymphocytes which can be very active APC
and yet are remarkably less effective than macrophages in ac-
cumulating endocytic tracers (our unpublished observations) .
rho-ova is one of the more sensitive tracers for detecting
pinocytosis by dendritic cells (23) (Fig. 2) . Uptake of agents
like lucifer yellow, FITC-dextran, horseradish peroxidase, cas-
cade blue ovalbumin, are all undetectable using the exposure
conditions required for antigen pulsing ; i .e ., 0.1 mg/ml for
12-16 h (data not shown) . Because of the low level of pino-
cytic activity, we have not been able to quantitate uptake rates
in fresh and cultured LC .
Both fresh and cultured LC can internalize rho-ova (Fig .
2), so that uptake per se is not the explanation for differences
in antigen processing . We have not tested the acidity of the
intracellular vacuoles that were labeled with rho-ova . There-
fore it remains possible that the pH of endocytic vacuoles
in freshly isolated and culturedLC are significantly different,
an observation recently made by Stossel et al. (48) .
In most studies of antigen presentation in tissue culture,
antigen uptake primarily occurs through bulk or fluid phase
pinocytosis . Receptor-mediated uptake may enhance the
efficiency of presentation. Fresh LC have Fc receptors, and
these are downregulated during culture (24, 44) . These Fc
receptors might enhance the uptake and processing activity
of freshly isolated LC as long as antibody is present . Also,
we have observed uptake of horseradish peroxidase by fresh
but not cultured LC using a dose of 1 mg/ml (our unpub-lished observations) . Perhaps freshly isolated LC selectively
express mannose receptors and for this reason are able to cap-
ture some peroxidase and other glycoproteins by adsorptive
uptake.
Role of Newly Synthesized Class II Products in Presentation
ofExogenous Proteins. The importance of newly synthesized
MHC molecules has been emphasized for presentation by class
I products . Peptides derived from the cytoplasm (5), or per-
haps from the external environment (20), likely associate with
the forming class 1-/3z microglobulin heterodimer. It may
be quantitatively inefficient for peptides to gain access to pep-
tide binding grooves at the cell surface, because these grooves
are already occupied . Our results provide a biologic model
in which biosynthesis ofclass IIMHC molecules also corre-
lates with the efficacy of presentation . Immediately upon
testing in vitro, incorporation of [35S]methionine into class
II is at least 5-20 times more active in LC than in any other
cell, and within 20 h, biosynthesis effectively ceases. Like-
wise fresh LC are efficient at processing foreign proteins, and
within a day activity drops markedly (Figs. 1 and 3) . Perhaps
processed foreign proteins and newly synthesized class II in-
teract in a late endosome (49) .
There is recent evidence that invariant chains, which are
abundant in fresh but not cultured LC (Figs . 5 and 6), are
required for presentation by L cells that have been transfected
with class II genes (38) . It has been hypothesized that an
amphipathic ct-helical region within the invariant chain oc-
cupies the class Il peptide binding groove before entry of a
foreign peptide (50) . Occupancy by invariant chain may be
important to protect the groove from peptides that are present
in the secretory pathway, which may be the site in which
peptides gain access to class I (5, 20) . In an acidic endocytic
compartment, the invariant chain could be displaced or
degraded (15) . Unoccupied, newly synthesized class II might
be more accessible to exogenous peptide .
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Presentation by class II products in epidermal LC is blocked
by CHX . The sensitivity toCHX is similar to that described
by Jensen for mouse peritoneal cells (16). Our studies impli-
cate the class II heterodimer as the CHX-sensitive site, but
the evidence is correlative at this time. We have attempted
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takes to prepare the cells.
In contrast to LC, treatment with CHX does not block
presentation by anti-Ig-activated B lymphoblasts, and in fact,
CHX consistently enhances presentation (Table 2) . The
findings are consistent with similar results in a B cell lym-
phoma (17) .
Regulation of Class II MHC Biosynthesis in Dendritic
Cells. The mechanism of regulation of MHC biosynthe-
size in LC is unclear. The cytokine granulocyte/macrophage
(GM)-CSF influences LC viability and function (51, 52), but
we have been unable to block the upregulation of class II
with anti-GM-CSF (our unpublished observations) . The regu-
lation in dendritic cells is likely to be different from other
leukocytes. For macrophages (32) andB cells (53), T cell prod-
ucts like IFN-'y and IL4 induce class II biosynthesis. Yet in
our studies, we are using populations that are depleted of
thy-1+ T cells of either a/R or y/S variety.
The regulation ofMHC expression on dendritic cells re-
mains a criticalunknown for the further analysis of the findings
reported here, since as mentioned, it is not yet possible to
selectively inhibit LC at the level of class II mRNA. By
blocking the signals that upregulate class II, it may be pos-
sible to interrupt antigen presentation and immunogenicity
at a very early step.
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